IMMUNE RESPONSE UPON THE ADMINISTRATION OF RECOMBINANT PROTEIN ANTIBODIES Ag-38 KDa Mycobacterium tuberculosis AND RIFAMPICIN EX-VIVO

BACKGROUND: Development a granuloma model resembling latent tuberculosis in vitro is needed with a fast and efficient time to be used as an effective therapy. This study aimed to form efficient granulomas, increase cellular immunity and humoral immunity, and evaluate growth on media using recombinan...

Descripción completa

Detalles Bibliográficos
Autores principales: Raras, Tri Yudani Mardining, Fahrinda, Almira, Yuliati, Nurhidayati, Dwi Yuni, Sujuti, Hidayat, Prawiro, Sumarno Reto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: African Traditional Herbal Medicine Supporters Initiative (ATHMSI) 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097312/
https://www.ncbi.nlm.nih.gov/pubmed/35582059
http://dx.doi.org/10.21010/Ajid.v16i2.8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097312/
https://www.ncbi.nlm.nih.gov/pubmed/35582059
http://dx.doi.org/10.21010/Ajid.v16i2.8

Ejemplares similares